4
Changes in Ownership
Summit Therapeutics Inc. Filed Acc 0000921895-20-002948
Options or other derivatives
- Director acquired 203,323 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X03/form412566001_11132020.xml…